BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,055 filers reported holding BAXTER INTL INC in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,385,039 | -41.4% | 195,682 | -29.3% | 0.02% | -35.5% |
| Q2 2023 | $12,602,898 | +347.1% | 276,622 | +298.0% | 0.03% | +342.9% |
| Q1 2023 | $2,818,920 | -51.4% | 69,500 | -38.9% | 0.01% | -56.2% |
| Q4 2022 | $5,802,272 | -2.8% | 113,837 | +2.7% | 0.02% | -5.9% |
| Q3 2022 | $5,970,000 | -19.1% | 110,846 | -3.6% | 0.02% | -15.0% |
| Q2 2022 | $7,384,000 | -16.7% | 114,961 | +0.6% | 0.02% | 0.0% |
| Q1 2022 | $8,864,000 | -5.7% | 114,320 | +4.4% | 0.02% | +17.6% |
| Q4 2021 | $9,398,000 | +4.2% | 109,485 | -2.3% | 0.02% | 0.0% |
| Q3 2021 | $9,016,000 | -24.5% | 112,096 | -24.5% | 0.02% | -22.7% |
| Q2 2021 | $11,946,000 | -51.4% | 148,404 | -49.1% | 0.02% | -54.2% |
| Q1 2021 | $24,584,000 | -8.2% | 291,488 | -12.6% | 0.05% | -12.7% |
| Q4 2020 | $26,775,000 | -26.4% | 333,677 | -26.2% | 0.06% | -35.3% |
| Q3 2020 | $36,378,000 | -28.4% | 452,359 | -23.3% | 0.08% | -32.5% |
| Q2 2020 | $50,779,000 | +8.0% | 589,762 | +1.8% | 0.13% | -8.7% |
| Q1 2020 | $47,018,000 | -24.3% | 579,103 | -22.1% | 0.14% | -0.7% |
| Q4 2019 | $62,144,000 | -29.4% | 743,180 | -26.2% | 0.14% | -35.6% |
| Q3 2019 | $88,062,000 | +3.7% | 1,006,780 | -2.9% | 0.22% | +4.9% |
| Q2 2019 | $84,950,000 | -12.2% | 1,037,239 | -12.8% | 0.21% | -13.8% |
| Q1 2019 | $96,773,000 | +13.9% | 1,190,176 | -7.8% | 0.24% | +3.5% |
| Q4 2018 | $84,930,000 | -23.9% | 1,290,349 | -10.9% | 0.23% | -11.2% |
| Q3 2018 | $111,612,000 | +111.1% | 1,447,814 | +102.2% | 0.26% | +67.7% |
| Q2 2018 | $52,863,000 | +4.0% | 715,900 | -8.4% | 0.16% | +4.7% |
| Q1 2018 | $50,837,000 | -13.6% | 781,621 | -14.2% | 0.15% | -10.8% |
| Q4 2017 | $58,861,000 | +47.1% | 910,603 | +42.8% | 0.17% | +44.3% |
| Q3 2017 | $40,018,000 | +5.9% | 637,736 | +2.2% | 0.12% | +5.5% |
| Q2 2017 | $37,773,000 | -27.6% | 623,944 | -38.0% | 0.11% | -26.8% |
| Q1 2017 | $52,198,000 | -16.8% | 1,006,526 | -28.9% | 0.15% | -20.7% |
| Q4 2016 | $62,731,000 | +4.8% | 1,414,777 | +12.5% | 0.19% | +9.3% |
| Q3 2016 | $59,862,000 | +61.3% | 1,257,610 | +53.2% | 0.17% | +59.3% |
| Q2 2016 | $37,110,000 | -13.0% | 820,650 | -21.0% | 0.11% | -18.2% |
| Q1 2016 | $42,660,000 | +4.2% | 1,038,459 | -3.2% | 0.13% | +1.5% |
| Q4 2015 | $40,933,000 | +13682.2% | 1,072,957 | +11767.7% | 0.13% | +12900.0% |
| Q3 2015 | $297,000 | -66.4% | 9,041 | -28.5% | 0.00% | -66.7% |
| Q2 2015 | $884,000 | -61.2% | 12,640 | -62.0% | 0.00% | -57.1% |
| Q1 2015 | $2,278,000 | -2.4% | 33,248 | +4.4% | 0.01% | 0.0% |
| Q4 2014 | $2,333,000 | -14.2% | 31,835 | -16.0% | 0.01% | -22.2% |
| Q3 2014 | $2,719,000 | +5.5% | 37,879 | +6.3% | 0.01% | +12.5% |
| Q2 2014 | $2,577,000 | +51.0% | 35,643 | +53.7% | 0.01% | +33.3% |
| Q1 2014 | $1,707,000 | +5.2% | 23,196 | -0.5% | 0.01% | 0.0% |
| Q4 2013 | $1,622,000 | +4.0% | 23,324 | -1.7% | 0.01% | 0.0% |
| Q3 2013 | $1,559,000 | -9.7% | 23,733 | -4.8% | 0.01% | -14.3% |
| Q2 2013 | $1,726,000 | – | 24,917 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |